Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondation Ophtalmologique Adolphe de Rothschild

About this trial

The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient over 18 years old

Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist

For which a brain and visual MRI is planned

Express consent to participate in the study

Disqualifiers

Contraindication to MRI (electrical device, metallic foreign body, claustrophobia)

Patient benefiting from a legal protection measure

Pregnant or breastfeeding woman

Trial population

Patients with suspected NOIA, discussed after clinical examination by a specialist ophthalmologist

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • MRI

    Other intervention

    Diffusion sequence (8 minutes long) added to the initial MRI

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Study the sensitivity of the High resolution Diffusion sequence in the detection of NOIA, evaluated by a DWI hypersignal and an ADC hyposignal of the optic nerve

Time frame
basline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.